Sagimet Biosciences Inc.

SGMT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.5B · 16 employees
67
SEC Filings
$7.73
Close 2026-06-30
16
Employees

Business Summary

PART I Overview We are a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Our lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Our ...

Latest Stock Quote

SGMT 2026-06-30 $7.73 O:$7.7 H:$7.84 L:$7.42 Vol:0.9M VWAP:$7.6761
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-112025-12-310001104659-26-026140EDGAR107K words
2025-03-122024-12-310001558370-25-002747EDGAR
2024-03-252023-12-310001558370-24-003812EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-112026-06-300001193125-26-343441EDGAR
2025-11-132025-09-300001104659-25-110846EDGAR20K words
2025-08-132025-06-300001558370-25-011301EDGAR
2025-05-082025-03-310001558370-25-006836EDGAR
2024-11-142024-09-300001558370-24-015623EDGAR
2024-08-142024-06-300001558370-24-012136EDGAR
2024-05-152024-03-310001558370-24-008205EDGAR
2023-11-132023-09-300001558370-23-018700EDGAR
2023-08-212023-06-300001104659-23-093910EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-130001193125-26-347854EDGAR
2026-08-110001193125-26-343446EDGAR
2026-07-210001193125-26-309334EDGAR
2026-03-110001104659-26-026146EDGAR7K words
2026-02-020001104659-26-008925EDGAR
2025-12-180001104659-25-122272EDGAR
2025-12-170001104659-25-121819EDGAR
2025-11-130001104659-25-110852EDGAR
2025-10-230001104659-25-101819EDGAR
2025-08-220001104659-25-081630EDGAR

67 total filings indexed. 45 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Company Identity

CIK0001400118
TickerSGMT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.sagimet.com
Listed2023-07-14

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d48c82bda00f2b1c04c0402183e32fe20603d4a6b24f76452f97814b6f702662
parent: b0dd111c1876037c80d6597a124fb383a856ed9b61017d22f224529638739798
content hash: e57d7695a06ed86f7807098deb51bd71e89c92907512efb12865fcd042e50aaa
signed: 2026-08-13T19:06:15.037Z
sources: 12 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up SGMT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on SGMT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/SGMT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.